What the Study Found (In Plain English)
Published in Cutis (1978), this randomized controlled trial evaluating human clinical outcomes investigated: Fifty patients with a diagnosis of psoriasis, eczematous dermatitis, atopic dermatitis, or neurodermatitis and with bilateral symmetric lesions of equal severity participated in this study. Key clinical takeaway: No side effects with either ointment were observed. Halcinonide as formulated in this combination is an effective and safe corticosteroid.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (Cutis, 1978-07-15; Randomized Controlled Trial; Rigor 88/100): No side effects with either ointment were observed. Halcinonide as formulated in this combination is an effective and safe corticosteroid.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.